VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec 16, 2014) - Naturally Splendid Enterprises ("Naturally Splendid") (TSX VENTURE:NSP)(NSPDF)(50N.F) announces that Full Spectrum Laboratories Limited ("FSL"), Boreal Technologies, Inc. ("Boreal"), Naturally Splendid USA Ltd., a wholly owned subsidiary of Naturally Splendid, ("Naturally Splendid USA") and Naturally Splendid have agreed to extend the outside date for closing of the previously announced Novation Agreement (see news release dated November 20, 2014) to January 15, 2015. No other terms of the Novation Agreement have changed.
The Novation Agreement is subject to a number of conditions including acceptance of the above transaction by the TSX Venture Exchange and Naturally Splendid completing its previously announced financing (see news releases dated November 27, 2014 and December 5, 2014). In the event that the transaction does not close by January 15, 2015, the Novation Agreement will be terminated and be of no further force or effect.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid has an exclusive sales agreement to market and distribute, in North America, the full complement of patent pending, plant-based omega products created by Boreal Technologies. The products include HempOmega™ and H2Omega™, as well as the FlaxOmega™, CanolaOmega™, and ChiaOmega™ plant based omega products. These novel products utilize microencapsulation and are available in both a powder format and an aqueous solution for increased flexibility in ingredient applications and stand-alone products.
Naturally Splendid's 100% owned NATERA™ line of hemp-based superfood products are carried nationwide by Canada's leading health food distributors and a network of retail stores across Canada including major retailers and specialty stores. Naturally Splendid's recently rebranded "NATERA™" line of products includes natural and flavored shelled hemp seeds as well as natural and flavored hemp protein powders.
About Full Spectrum Labs Limited
Full Spectrum Laboratories, LTD. Incorporated in Ireland, is a bioresearch and product development company with operating subsidiaries in Canada and the United States. The company has principally focused on the plant cannabis sativa and has developed numerous technologies and made several discoveries resulting in two granted patents and over 11 patent applications, in just under 5 years. FSL currently concentrates on formulation and extraction technologies; analytical cannabis testing in Canada; advance cannabis plant breeding specializing in CBD expression; and cannabinoid bio-synthesis.
For more information e-mail firstname.lastname@example.org or call 604-673-9573.
On Behalf of the Board of Directors
J. Craig Goodwin, CEO, Director
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.